Enrollment with advanced generation device for complete cerebral protection nearing halfway mark in clinical study in Germany and Poland Protembis GmbH, a privately held emerging medical device ...

SENTINEL trial to evaluate the Safety and Efficacy of the Sentinel CPS in TAVR population SANTA ROSA, CA. -- Claret Medical, Inc., a developer of innovative solutions for cerebral protection during ...

Please provide your email address to receive an email when new articles are posted on . Adults who underwent transcatheter aortic valve replacement with a cerebral protection system experienced fewer ...

SANTA ROSA, Calif.--(BUSINESS WIRE)--Claret Medical® today announced that it has received regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Sentinel™ Cerebral Protection ...

LONDON, England—Real-world use of cerebral embolic protection in patients undergoing TAVR for severe symptomatic aortic stenosis lowers the rate of periprocedural stroke when compared against TAVR ...

- Latest Generation Device in Embolic Capture and Removal for Reducing Stroke during TAVR Procedures SANTA ROSA, California, Jan. 27, 2014 /PRNewswire/ -- Claret Medical, Inc., a developer of ...

CAESAREA, Israel and TAMPA, Fla., Feb. 27, 2017 /PRNewswire/ -- Keystone Heart Ltd., an emerging medical device company focused on developing cerebral embolic protection devices for patients ...

MARLBOROUGH, Mass., Sept. 17, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) has announced results from the PROTECTED TAVR clinical trial evaluating the SENTINEL™ Cerebral Protection ...

Apollo Hospitals Chennai conducted a successful procedure using the Sentinel Cerebral Protection System, a new technology to help protect patients from the risk of stroke during a minimally invasive ...

Please provide your email address to receive an email when new articles are posted on . The device (TriGuard 3, Keystone Heart) showed potential to prevent larger ischemic brain lesions, Jeffrey W.

AACHEN, Germany--(BUSINESS WIRE)--Protembis GmbH, a privately held emerging medical device company, announced today the successful completion of 20 clinical cases in its European regulatory study of ...